EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Lower NT-Probnp Plasma Concentrations in Pacific Peoples with Heart Failure

Andree G Pearson iD, John F Pearson, Lynley K Lewis, Allamanda Fa'atoese, Katrina K Poppe, Chris Pemberton, Gerry Devlin, Mayanna Lund, A Mark Richards, Richard Troughton, Robert N Doughty

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15314 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Andree G Pearson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Christchurch Heart Institute, Department of Medicine, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Heart Failure, Natriuretic Peptide, Brain, Peptide Fragments, Ventricular Function, Left. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Council of New Zealand, National Heart Foundation of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Plasma concentrations of the heart failure (HF) biomarker N-terminal B-type natriuretic peptide (NT-proBNP) vary by ethnicity. We investigated whether NT-proBNP concentrations differed in HF between Pacific peoples, Māori (the Indigenous people), and New Zealand (NZ) Europeans, in patients with HF.

Methods

Plasma NT-proBNP was measured in patients with HF participating in two prospective NZ based multicentre studies [PEOPLE: n = 836, 30% female, median age 71, interquartile interval (IQI) 60, 80; IMPERATIVE-HF: n = 413, 30% female, median age 66, IQI 55, 76]. Regression analyses were used to understand predictors of NT-proBNP taking into account age, sex, body mass index (BMI), estimated glomerular filtration rate (eGFR), left ventricular ejection fraction (LVEF) and presence of atrial fibrillation (AF).

Results

Median NT-proBNP concentrations were significantly lower in both Pacific (930 pg/mL; P < 0.001, IQI 409–1,473; n = 127) and Māori (1,387 pg/mL, IQI 685–2,393; P < 0.001; n = 221) compared with NZ Europeans (2,055 pg/mL, IQI 973–3,865; n = 901) in unadjusted comparisons. NT-proBNP was independently associated with ethnicity, age, sex, BMI, eGFR, LVEF and presence of AF. The significant differences in plasma NT-proBNP between Pacific peoples, but not Māori, and NZ Europeans remained after adjusting for these clinical and demographic factors. The effect of age on NT-proBNP concentrations differed significantly between Pacific peoples and NZ Europeans, but not between Māori and NZ European (Pinteraction = 0.0109). For each decade of life over 60 years, plasma NT-proBNP in patients with HF was on average, 67% lower in a Pacific person than that of an aged-matched NZ European.

Conclusions

In HF, Pacific and Māori people had significantly lower median plasma concentrations of NT-proBNP than NZ Europeans. This difference remained after adjusting for clinical and demographic factors in patients with Pacific ethnicity. Pacific peoples also had a significantly lower rate of increase of NT-proBNP with age compared with NZ Europeans and Māori.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureNatriuretic Peptide, BrainPeptide FragmentsVentricular Function, LeftAgedAged, 80 and overFemaleHumansMaleMiddle AgedBiomarkersFollow-Up StudiesGlomerular Filtration RateNew ZealandProspective StudiesStroke Volume

Stichwörter der Autor:innen

NT‐proBNPethnicityheart failure

Substanzen

BiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Christchurch Heart Institute, Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Department of Medicine Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Department of Cardiology Gisborne Hospital, Tairāwhiti, Health New Zealand Te Whatu Ora Gisborne, New Zealand.
  • Cardiology Department, Middlemore Hospital, Health New Zealand Te Whatu Ora, Auckland, New Zealand.
  • Cardiology Department, Auckland City Hospital, Health New Zealand Te Whatu Ora, Auckland, New Zealand.

ORCID-Profile: Andree G Pearson

Förderung

  • Health Research Council of New Zealand
  • National Heart Foundation of New Zealand

Zitieren

APA

Pearson, A. G., Pearson, J. F., Lewis, L. K., Fa'atoese, A., Poppe, K. K., Pemberton, C., Devlin, G., Lund, M., Richards, A. M., Troughton, R., & Doughty, R. N. (2025). Lower NT-Probnp Plasma Concentrations in Pacific Peoples with Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.15314

Vancouver

Pearson AG, Pearson JF, Lewis LK, Fa'atoese A, Poppe KK, Pemberton C, et al. Lower NT-Probnp Plasma Concentrations in Pacific Peoples with Heart Failure. ESC Heart Failure. 2025. doi:10.1002/ehf2.15314

BibTeX
@article{Pearson2025,
  author = {Pearson, Andree G and Pearson, John F and Lewis, Lynley K and Fa'atoese, Allamanda and Poppe, Katrina K and Pemberton, Chris and Devlin, Gerry and Lund, Mayanna and Richards, A Mark and Troughton, Richard and Doughty, Robert N},
  title = {Lower NT-Probnp Plasma Concentrations in Pacific Peoples with Heart Failure},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15314}
}
Kostenlos starten →